UK markets closed

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.0896+0.0088 (+10.89%)
At close: 03:59PM EDT
0.0907 +0.00 (+1.23%)
After hours: 04:10PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
12,151
14,726
14,404
10,204
9,934
Cost of revenue
5,317
6,831
6,623
3,689
3,970
Gross profit
6,834
7,895
7,781
6,515
5,964
Operating expenses
Research development
116
68
174
44
285
Selling general and administrative
14,903
12,830
15,287
15,333
12,105
Total operating expenses
15,019
12,898
15,461
15,377
12,390
Operating income or loss
-8,185
-5,003
-7,680
-8,862
-6,426
Total other income/expenses net
5,625
-4,637
-2,928
3,038
-4,608
Income before tax
-2,560
-9,640
-10,608
-5,824
-11,034
Income tax expense
0
-
-
0
5
Income from continuing operations
-2,560
-9,640
-10,608
-5,824
-11,039
Net income
-2,560
-9,640
-10,608
-5,824
-11,039
Net income available to common shareholders
-8,952
-16,697
-16,265
-6,559
-11,039
Basic EPS
-7.05
-
-10.10
-5.26
-10.85
Diluted EPS
-7.05
-
-10.10
-5.26
-10.85
Basic average shares
2,958
-
1,610
1,247
1,002
Diluted average shares
2,958
-
1,610
1,247
1,002